0890 100 62 - WURTH B+S PLASTIC/WOOD/STONE PRIMER 250ML

ChemWatch Material Safety Data Sheet

Issue Date: Thu 30-Sep-2004

CHEMWATCH 4719-84

Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

0890 100 62 - WURTH B+S PLASTIC/WOOD/STONE PRIMER 250ML

SYNONYMS

Manufacturer's Code: 0890 100 62

PROPER SHIPPING NAME

RESIN SOLUTION

PRODUCT USE

Primer / adhesion promoter. The use of a quantity of material in an unventilated or
confined space may result in increased exposure and an irritating atmosphere developing
Before starting consider control of exposure by mechanical ventilation

SUPPLIER

Company: Wurth Australia Pty Ltd      
Address:                              
4 Redwood Drive (abn 48 002 487 096)  
Dingley                               
VIC, 3175                             
AUSTRALIA                             
Telephone: (+61 3) 9552 9552          
Telephone: 1800 331 603               
Emergency Tel: 1300 657 765           
Fax: 03 9551 2994                     
                                      

Section 2 - HAZARDS IDENTIFICATION

STATEMENT OF HAZARDOUS NATURE

HAZARDOUS SUBSTANCE. DANGEROUS GOODS.

According to the Criteria of NOHSC, and the ADG Code.

POISONS SCHEDULE

S5

RISK

Highly flammable.
Contact with water liberates highly flammable gases.
Irritating to eyes and respiratory system.
HARMFUL-May cause lung damage if swallowed.
Repeated exposure may cause skin dryness and cracking.
Vapours may cause drowsiness and dizziness.

SAFETY

Never add water to this product.
Keep away from sources of ignition. No smoking.
Do not breathe gas/fumes/vapour/spray.
Wear eye/face protection.
Use only in well ventilated areas.
Keep container in a well ventilated place.
Do not empty into drains.
Keep container tightly closed.
Take off immediately all contaminated clothing.
In case of contact with eyes, rinse with plenty of water and contact Doctor or
Poisons Information Centre.
If you feel unwell contact Doctor or Poisons Information Centre. (Show the label
if possible).

Section 3 - COMPOSITION / INFORMATION ON INGREDIENTS

NAME CAS RN %
ethyl acetate 141-78-6 25-50
methyl ethyl ketone 78-93-3 10-25
n-butyl acetate 123-86-4 2.5-10
polyisocyanate 2.5-10
solvent, as 1-2.5
xylene 1330-20-7
2-methoxy-1-methylethyl cyanoacetate 32804-79-8 1-2.5
3-mercaptopropyltrimethoxysilane 4420-74-0 <2.5

Section 4 - FIRST AID MEASURES

SWALLOWED

· If swallowed do NOT induce vomiting.
· If vomiting occurs, lean patient forward or place on left side (head-down
position, if possible) to maintain open airway and prevent aspiration.
· Observe the patient carefully.
· Never give liquid to a person showing signs of being sleepy or with reduced
awareness; i.e. becoming unconscious.
· Give water to rinse out mouth, then provide liquid slowly and as much as
casualty can comfortably drink.
· Seek medical advice.

EYE

If this product comes in contact with the eyes:
· Wash out immediately with fresh running water.
· Ensure complete irrigation of the eye by keeping eyelids apart and away from
eye and moving the eyelids by occasionally lifting the upper and lower lids.
· If pain persists or recurs seek medical attention.
· Removal of contact lenses after an eye injury should only be undertaken by
skilled personnel.

SKIN

If skin contact occurs:
· Immediately remove all contaminated clothing, including footwear
· Flush skin and hair with running water (and soap if available).
· Seek medical attention in event of irritation.

INHALED

· If fumes or combustion products are inhaled remove from contaminated area.
· Lay patient down. Keep warm and rested.
· Prostheses such as false teeth, which may block airway, should be removed,
where possible, prior to initiating first aid procedures.
· Apply artificial respiration if not breathing, preferably with a demand valve
resuscitator, bag-valve mask device, or pocket mask as trained. Perform CPR if
necessary.
· Transport to hospital, or doctor.

NOTES TO PHYSICIAN

Treat symptomatically.
for simple esters:
--------------------------------------------------------------------------------
----------------------------------------
BASIC TREATMENT
--------------------------------------------------------------------------------
---------------------------------------
· Establish a patent airway with suction where necessary.
· Watch for signs of respiratory insufficiency and assist ventilation as
necessary.
· Administer oxygen by non-rebreather mask at 10 to 15 l/min.
· Monitor and treat, where necessary, for pulmonary oedema .
· Monitor and treat, where necessary, for shock.
· DO NOT use emetics. Where ingestion is suspected rinse mouth and give up to
200 ml water (5 ml/kg recommended) for dilution where patient is able to
swallow, has a strong gag reflex and does not drool.
· Give activated charcoal.
--------------------------------------------------------------------------------
---------------------------------------
ADVANCED TREATMENT
--------------------------------------------------------------------------------
---------------------------------------
· Consider orotracheal or nasotracheal intubation for airway control in
unconscious patient or where respiratory arrest has occurred.
· Positive-pressure ventilation using a bag-valve mask might be of use.
· Monitor and treat, where necessary, for arrhythmias.
· Start an IV D5W TKO. If signs of hypovolaemia are present use lactated Ringers
solution. Fluid overload might create complications.
· Drug therapy should be considered for pulmonary oedema.
· Hypotension with signs of hypovolaemia requires the cautious administration of
fluids. Fluid overload might create complications.
· Treat seizures with diazepam.
· Proparacaine hydrochloride should be used to assist eye irrigation.
--------------------------------------------------------------------------------
----------------------------------------
EMERGENCY DEPARTMENT
--------------------------------------------------------------------------------
----------------------------------------
· Laboratory analysis of complete blood count, serum electrolytes, BUN,
creatinine, glucose, urinalysis, baseline for serum aminotransferases (ALT and
AST), calcium, phosphorus and magnesium, may assist in establishing a treatment
regime. Other useful analyses include anion and osmolar gaps, arterial blood
gases (ABGs), chest radiographs and electrocardiograph.
· Positive end-expiratory pressure (PEEP)-assisted ventilation may be required
for acute parenchymal injury or adult respiratory distress syndrome.
· Consult a toxicologist as necessary.
BRONSTEIN, A.C. and CURRANCE, P.L. EMERGENCY CARE FOR HAZARDOUS MATERIALS
EXPOSURE: 2nd Ed. 1994

Section 5 - FIRE FIGHTING MEASURES

EXTINGUISHING MEDIA

· Alcohol stable foam.
· Dry chemical powder.
· BCF (where regulations permit).
· Carbon dioxide.
· Water spray or fog - Large fires only.

FIRE FIGHTING

· Alert Fire Brigade and tell them location and nature of hazard.
· May be violently or explosively reactive.
· Wear breathing apparatus plus protective gloves.
· Prevent, by any means available, spillage from entering drains or water
course.
· Consider evacuation (or protect in place).
· Fight fire from a safe distance, with adequate cover.
· If safe, switch off electrical equipment until vapour fire hazard removed.
· Use water delivered as a fine spray to control the fire and cool adjacent
area.
· Avoid spraying water onto liquid pools.
· Do not approach containers suspected to be hot.
· Cool fire exposed containers with water spray from a protected location.
· If safe to do so, remove containers from path of fire.
When any large container (including road and rail tankers) is involved in a fire,
consider evacuation by 500 metres in all directions.

FIRE/EXPLOSION HAZARD

· Liquid and vapour are highly flammable.
· Severe fire hazard when exposed to heat, flame and/or oxidisers.
· Vapour may travel a considerable distance to source of ignition.
· Heating may cause expansion or decomposition leading to violent rupture of
containers.
· On combustion, may emit toxic fumes of carbon monoxide (CO).
Combustion products include , carbon dioxide (CO2) , other pyrolysis products
typical of burning organic material

FIRE INCOMPATIBILITY

Avoid contamination with oxidising agents i.e. nitrates, oxidising acids,
chlorine bleaches, pool chlorine etc. as ignition may result

HAZCHEM

3[Y]E

Personal Protective Equipment

PERSONAL PROTECTION EQUIPMENT
Gloves, boots (chemical resistant)
Breathing apparatus.

Section 6 - ACCIDENTAL RELEASE MEASURES

EMERGENCY PROCEDURES

MINOR SPILLS

· Remove all ignition sources.
· Clean up all spills immediately.
· Avoid breathing vapours and contact with skin and eyes.
· Control personal contact by using protective equipment.
· Contain and absorb small quantities with vermiculite or other absorbent
material.
· Wipe up.
· Collect residues in a flammable waste container.

MAJOR SPILLS

· Clear area of personnel and move upwind.
· Alert Fire Brigade and tell them location and nature of hazard.
· May be violently or explosively reactive.
· Wear breathing apparatus plus protective gloves.
· Prevent, by any means available, spillage from entering drains or water
course.
· Consider evacuation (or protect in place).
· No smoking, naked lights or ignition sources.
· Increase ventilation.
· Stop leak if safe to do so.
· Water spray or fog may be used to disperse /absorb vapour.
· Contain spill with sand, earth or vermiculite.
· Use only spark-free shovels and explosion proof equipment.
· Collect recoverable product into labelled containers for recycling.
· Absorb remaining product with sand, earth or vermiculite.
· Collect solid residues and seal in labelled drums for disposal.
· Wash area and prevent runoff into drains.
· If contamination of drains or waterways occurs, advise emergency services.

PROTECTIVE ACTIONS FOR SPILL

From IERG (Canada/Australia)
Isolation Distance            25 metres
Downwind Protection Distance  300 metres
IERG Number                   14

 

FOOTNOTES
1  PROTECTIVE ACTION ZONE is defined as the area in which people are at risk
   of harmful exposure. This zone assumes that random changes in wind direction
   confines the vapour plume to an area within 30 degrees on either side of the
   predominant wind direction, resulting in a crosswind protective action distance
   equal to the downwind protective action distance.
2  PROTECTIVE ACTIONS should be initiated to the extent possible, beginning with
   those closest to the spill and working away from the site in the downwind
   direction. Within the protective action zone a level of vapour concentration
   may exist resulting in nearly all unprotected persons becoming incapacitated
   and unable to take protective action and/or incurring serious or irreversible
   health effects.
3  INITIAL ISOLATION ZONE is determined as an area, including upwind of the
   incident, within which a high probability of localised wind reversal may
   expose nearly all persons without appropriate protection to life-threatening
   concentrations of the material.
4  SMALL SPILLS involve a leaking package of 200 litres (55 US gallons) or less,
   such as a drum (jerrican or box with inner containers). Larger packages leaking
   less than 200 litres and compressed gas leaking from a small cylinder are also
   considered "small spills".
   LARGE SPILLS involve many small leaking packages or a leaking package of
   greater than 200 litres, such as a cargo tank, portable tank or a "one-tonne"
   compressed gas cylinder.
5  Guide 127 is taken from the US DOT emergency response guide book.
6  IERG information is derived from CANUTEC - Transport Canada.

EMERGENCY RESPONSE PLANNING GUIDLINES (ERPG)

The maximum airborne concentration below which it is believed that nearly all 
individuals could be exposed for up to one hour WITHOUT experiencing or developing

  life-threatening health effects is:
    n-butyl acetate  3000 ppm

  irreversible or other serious effects or symptoms which could 
  impair an individual's ability to take protective action is:
    n-butyl acetate  200 ppm

  other than mild, transient adverse effects
  without perceiving a clearly defined odour is:
    n-butyl acetate  5 ppm

American Industrial Hygiene Association (AIHA)

 

Personal Protective Equipment advice is contained in Section 8 of the MSDS.

Section 7 - HANDLING AND STORAGE

PROCEDURE FOR HANDLING

Contains low boiling substance:
Storage in sealed containers may result in pressure buildup causing violent
rupture of containers not rated appropriately.
· Check for bulging containers.
· Vent periodically
· Always release caps or seals slowly to ensure slow dissipation of vapours.
· Avoid all personal contact, including inhalation.
· Wear protective clothing when risk of exposure occurs.
· Use in a well-ventilated area.
· Prevent concentration in hollows and sumps.
· DO NOT enter confined spaces until atmosphere has been checked.
· Avoid smoking, naked lights, heat or ignition sources.
· When handling, DO NOT eat, drink or smoke.
· Vapour may ignite on pumping or pouring due to static electricity.
· DO NOT use plastic buckets.
· Earth and secure metal containers when dispensing or pouring product.
· Use spark-free tools when handling.
· Avoid contact with incompatible materials.
· Keep containers securely sealed.
· Avoid physical damage to containers.
· Always wash hands with soap and water after handling.
· Work clothes should be laundered separately.
· Use good occupational work practice.
· Observe manufacturer's storing and handling recommendations.
· Atmosphere should be regularly checked against established exposure standards
to ensure safe working conditions.
DO NOT allow clothing wet with material to stay in contact with skin

SUITABLE CONTAINER

Packing as supplied by manufacturer. Plastic containers may only be used if
approved for flammable liquid. Check that containers are clearly labelled and
free from leaks.

STORAGE INCOMPATIBILITY

Contact with water liberates highly flammable gases.
Avoid reaction with oxidising agents

STORAGE REQUIREMENTS

· Store in original containers in approved flame-proof area.
· No smoking, naked lights, heat or ignition sources.
· DO NOT store in pits, depressions, basements or areas where vapours may be
trapped.
· Keep containers securely sealed.
· Store away from incompatible materials in a cool, dry well ventilated area.
· Protect containers against physical damage and check regularly for leaks.
· Observe manufacturer's storing and handling recommendations.

Section 8 - EXPOSURE CONTROLS / PERSONAL PROTECTION

EXPOSURE CONTROLS

No data available for ethyl acetate as (CAS: 141-78-6) / (CAS: 78-93-3) / (CAS: 123-86-4)
  / (CAS: 1330-20-7) / (CAS: 32804-79-8) / (CAS: 4420-74-0)

ODOUR SAFETY FACTOR (OSF)

    OSF=2 (3-mercaptopropyltrimethoxysilane)
    Exposed individuals are NOT reasonably expected to be warned, by smell, that the
    Exposure Standard is being exceeded.
    Odour Safety Factor (OSF) is determined to fall into either Class C, D or E.
    The Odour Safety Factor (OSF) is defined as:
    OSF= Exposure Standard (TWA) ppm/ Odour Threshold Value (OTV) ppm
    Classification into classes follows:
    
    Class  OSF     Description
    A      550     Over 90% of exposed
                   individuals are aware by
                   smell that the Exposure
                   Standard (TLV-TWA for
                   example) is being
                   reached, even when
                   distracted by working
                   activities
    B      26-550  As "A" for 50-90% of
                   persons being distracted
    C      1-26    As "A" for less than 50%
                   of persons being
                   distracted
    D      0.18-1  10-50% of persons aware
                   of being tested perceive
                   by smell that the
                   Exposure Standard is
                   being reached
    E      <0.18   As "D" for less than 10%
                   of persons aware of being
                   tested

EXPOSURE STANDARDS FOR MIXTURE

    "Worst Case" computer-aided prediction of vapour components/concentrations:
     
    Composite Exposure Standard for Mixture (TWA) (mg/m³): 1207.2509 mg/m³
    If the breathing zone concentration of ANY of the components listed below is
    exceeded, "Worst Case" considerations deem the individual to be overexposed.
    Component Breathing Zone ppm Breathing Zone mg/m³ Mixture Conc: (%)
    
    Component            Breathing zone  Breathing Zone  Mixture Conc
                         (ppm)           (mg/m³)         (%)
    ethyl acetate                        709.3131        50.0
    xylene               0.32            1.4186          0.1
    methyl ethyl ketone  119.55          354.6565        25.0
    n-butyl acetate      29.84           141.8626        10.0
     
    Operations which produce a spray/mist or fume/dust, introduce particulates to
    the breathing zone.
    If the breathing zone concentration of ANY of the components listed below is
    exceeded, "Worst Case" considerations deem the individual to be overexposed.
    At the "Composite Exposure Standard for Mixture" (TWA) (mg/m³): 35.1 mg/m³

REPRODUCTIVE HEALTH GUIDELINES

    Established occupational exposure limits frequently do not take into
    consideration reproductive end points that are clearly below the thresholds for
    other toxic effects. Occupational reproductive guidelines (ORGs) have been
    suggested as an additional standard. These have been established after a
    literature search for the reproductive no-observed-adverse effect-level (NOAEL)
    and the lowest-observed-adverse-effect-level (LOAEL). In addition the US EPA's
    procedures for risk assessment for hazard identification and dose-response
    assessment as applied by NIOSH were used in the creation of such limits.

                                                                            TLV
Ingredient            ORG                UF        Endpoint       CR        Adeq
methyl ethyl ketone   590 mg/m³          NA        NA             NA        Yes
    These exposure guidelines have been derived from a screening level of risk
    assessment and should not be construed as unequivocally safe limits. ORGS
    represent an 8-hour time-weighted average unless specified otherwise.
    CR = Cancer Risk/10000; UF = Uncertainty factor:
    TLV believed to be adequate to protect reproductive health:
    LOD: Limit of detection
    Toxic endpoints have also been identified as:
    D = Developmental; R = Reproductive; TC = Transplacental carcinogen
    Jankovic J., Drake F.: A Screening Method for Occupational Reproductive
    American Industrial Hygiene Association Journal 57: 641-649 (1996)

INGREDIENT DATA

ETHYL ACETATE:
   TLV TWA: 400 ppm [ACGIH]
   PEL TWA:  400 ppm, 1400 mg/m³ (SKIN) [OSHA Z1]
   ES TWA: 200 ppm; STEL 400 ppm
   TLV TWA: 400 ppm, 1440 mg/m³
   OES TWA: 400 ppm, 1460 mg/m³
   MAK value: 400 ppm, 1500 mg/m³
   MAK Category I Peak Limitation: For local irritants Allows excursions of twice
   the MAK value for 5 minutes at a time, 8 times per shift.
   MAK Group C: There is no reason to fear risk of damage to the developing embryo
   when MAK and BAT values are observed.
   MAK values, and categories and groups are those recommended within the
   Federal Republic of Germany
   IDLH Level: 2000 ppm (lower explosive limit)
   Odour Threshold Value: 6.4-50 ppm (detection), 13.3-75 ppm (recognition)

   The TLV-TWA provides a significant margin of safety from the standpoint of
   adverse health effects. Unacclimated subjects found the odour
   objectionably strong at 200 ppm. Mild nose, eye and throat irritation was
   experienced at 400 ppm. Workers exposed regularly at concentrations
   ranging from 375 ppm to 1500 ppm for several months showed no unusual
   signs or symptoms.

METHYL ETHYL KETONE:
   TLV TWA: 200 ppm BEI [ACGIH]
   TLV STEL: 300 ppm BEI [ACGIH]
   PEL TWA:  200 ppm, 590 mg/m³ [OSHA Z1]
   TLV TWA: 200 ppm, 590 mg/m³; STEL: 300 ppm, 885 mg/m³
   ES TWA: 150 ppm, 445 mg/m³; STEL: 300 ppm, 890 mg/m³
   OES TWA: 200 ppm, 600 mg/m³; STEL: 300 ppm, 899 mg/m³  skin
   MAK value: 200 ppm, 600 mg/m³
   Designated H in List of MAK values: Danger of cutaneous absorption.
   Absorption of such substances through the skin can pose an incomparably larger
   danger of toxicity than their inhalation. To avoid health risks when handling
   such substances, meticulous cleaning of the skin, hair and clothing is
   imperative.
   MAK Category I Peak Limitation: For local irritants Allows excursions of twice
   the MAK value for 5 minutes at a time, 8 times per shift.
   MAK Group C: There is no reason to fear risk of damage to the developing embryo
   when MAK and BAT values are observed.
   MAK values, and categories and groups are those recommended within the
   Federal Republic of Germany
   IDLH Level: 3000 ppm
   Odour Threshold Value: Variously reported as 2 ppm and 4.8 ppm
   Odour threshold:  2 ppm (detection);            5 ppm (recognition)
                    25 ppm (easy recognition);   300 ppm IRRITATING

   Exposures at or below the recommended TLV-TWA are thought to prevent
   injurious systemic effects and to minimise objections to odour and
   irritation. Where synergism or potentiation may occur stringent control of
   the primary toxin (e.g. n-hexane or methyl butyl ketone) is desirable and
   additional consideration should be given to lowering MEK exposures.

N-BUTYL ACETATE:
   TLV TWA: 150 ppm [ACGIH]
   TLV STEL: 200 ppm [ACGIH]
   PEL TWA:  150 ppm, 710 mg/m³ [OSHA Z1]
   TLV TWA: 150 ppm, 713 mg/m³; STEL: 200 ppm, 950 mg/m³
   ES TWA: 150 ppm, 713 mg/m³; STEL: 200 ppm, 950 mg/m³
   OES TWA: 150 ppm, 724 mg/m³; STEL: 200 ppm, 966 mg/m³
   MAK value: 100 ppm, 480 mg/m³
   MAK Category I Peak Limitation: For local irritants Allows excursions of twice
   the MAK value for 5 minutes at a time, 8 times per shift.
   MAK values, and categories and groups are those recommended within the
   Federal Republic of Germany
   Odour Threshold Value: 0.0063 ppm (detection), 0.038-12 ppm (recognition)
   IDLH Level: 1700 ppm (lower explosive limit)
   Exposure at or below the recommended TLV-TWA is thought to prevent
   significant irritation of the eyes and respiratory passages as well as
   narcotic effects. In light of the lack of substantive evidence regarding
   teratogenicity and a review of acute oral data a STEL is considered
   inappropriate.

XYLENE:
   TLV TWA: 100 ppm A4;BEI [ACGIH]
   TLV STEL: 150 ppm A4;BEI [ACGIH]
   PEL TWA:  100 ppm, 435 mg/m³ [OSHA Z1]
   TLV TWA: 100 ppm, 434 mg/m³; STEL: 150 ppm, 651 mg/m³  A4
   NOTE: This substance has been classified by the ACGIH as A4 NOT classifiable as
   causing Cancer in humans
   ES TWA: 80 ppm, 350 mg/m³; STEL: 150 ppm, 655 mg/m³ (Under review)
   OES TWA: 100 ppm, 441 mg/m³; STEL: 150 ppm, 662 mg/m³  skin
   Exposure limits with "skin" notation indicate that vapour and liquid may be
   absorbed through intact skin. Absorption by skin may readily exceed vapour
   inhalation exposure. Symptoms for skin absorption are the same as for
   inhalation. Contact with eyes and mucous membranes may also contribute to
   overall exposure and may also invalidate the exposure standard.
   IDLH Level: 900 ppm
   Odour Threshold Value: 20 ppm (detection), 40 ppm (recognition)
   NOTE: Detector tubes for o-xylene, measuring in excess of 10 ppm, are
         available commercially. (m-xylene and p-xylene give almost the same
         response)

   Xylene vapour is an irritant to the eyes, mucous membranes and skin and
   causes narcosis at high concentrations. Exposure to doses sufficiently high
   to produce intoxication and unconsciousness also produces transient liver
   and kidney toxicity. Neurologic impairment is NOT evident amongst
   volunteers inhaling up to 400 ppm though complaints of ocular and upper
   respiratory tract irritation occur at 200 ppm for 3 to 5 minutes.
   Exposure to xylene at or below the recommended TLV-TWA and STEL is thought
   to minimise the risk of irritant effects and to produce neither significant
   narcosis or chronic injury. An earlier skin notation was deleted because
   percutaneous absorption is gradual and protracted and does not
   substantially contribute to the dose received by inhalation.

2-METHOXY-1-METHYLETHYL CYANOACETATE:
   No exposure limits set by NOHSC or ACGIH

3-MERCAPTOPROPYLTRIMETHOXYSILANE:
   None assigned. Refer to individual constituents.

PERSONAL PROTECTION

EYE

· Safety glasses with side shields.
· Chemical goggles.
· Contact lenses pose a special hazard; soft lenses may absorb irritants and all
lenses concentrate them. DO NOT wear contact lenses.

HANDS/FEET

Wear chemical protective gloves, eg. PVC.
Wear safety footwear or safety gumboots, eg. Rubber

OTHER

· Overalls.
· PVC Apron.
· PVC protective suit may be required if exposure severe.
· Eyewash unit.
· Ensure there is ready access to a safety shower.

GLOVE SELECTION INDEX

Glove selection is based on a modified presentation of the:
"Forsberg Clothing Performance Index".
The effect(s) of the following substance(s) are taken into account in the
computer-generated selection:
  Substance
________________________________________
ethyl acetate      
methyl ethyl ketone
n-butyl acetate    
PE/EVAL/PE             A
PVA                    A
TEFLON                 B
BUTYL                  B
BUTYL/NEOPRENE         C
NEOPRENE/NATURAL       C
NITRILE+PVC            C
HYPALON                C
PVC                    C
NATURAL RUBBER         C
NEOPRENE               C
NITRILE                C
NATURAL+NEOPRENE       C
PE                     C

* CPI - Chemwatch Performance Index
A: Best Selection
B: Satisfactory; may degrade after 4 hours continuous immersion
C: Poor to Dangerous Choice for other than short term immersion
NOTE: As a series of factors will influence the actual performance of the glove,
a final selection must be based on detailed observation. -
* Where the glove is to be used on a short term, casual or infrequent basis,
factors such as "feel" or convenience (e.g. disposability), may dictate a choice
of gloves which might otherwise be unsuitable following long-term or frequent
use. A qualified practitioner should be consulted.

RESPIRATOR

Respiratory protection may be required when ANY "Worst Case" vapour-phase
concentration is exceeded (see Computer Prediction in "Exposure Standards").

Protection Factor (Min)  Half-Face Respirator  Full-Face Respirator
5 x ES                   A-AUS                 -
                         A-PAPR-AUS
25 x ES                  Air-line*             A-2
                                               A-PAPR-2
50 x ES                  -                     A-3
50+ x ES                 -                     Air-line**


* - Continuous-flow; ** - Continuous-flow or positive pressure demand
^ - Full-face

The local concentration of material, quantity and conditions of use determine
the type of personal protective equipment required. For further information
consult site specific CHEMWATCH data (if available), or your Occupational
Health and Safety Advisor.

ENGINEERING CONTROLS

For flammable liquids and flammable gases, local exhaust ventilation or a
process enclosure ventilation system may be required. Ventilation equipment
should be explosion-resistant.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

APPEARANCE

Transparent highly flammable liquid with an ester odour; reacts with
water.

PHYSICAL PROPERTIES

Liquid.

 

Molecular Weight: Not Applicable          Boiling Range (ºC): 77
Melting Range (ºC): Not Available         Specific Gravity (water=1): 1.0
Solubility in water (g/L): Reacts         pH (as supplied): ~7
pH (1% solution): Not Available           Vapour Pressure (kPa): 6.0 @ 20C
Volatile Component (%vol): Not Available  Evaporation Rate: Not Available
Relative Vapour Density (air=1): >1       Flash Point (ºC): -8
Lower Explosive Limit (%): 2              Upper Explosive Limit (%): 12
Autoignition Temp (ºC): >400              Decomposition Temp (ºC): Not Available
State: Liquid

Section 10 - CHEMICAL STABILITY AND REACTIVITY INFORMATION

CONDITIONS CONTRIBUTING TO INSTABILITY

· Presence of incompatible materials.
· Product is considered stable.
· Hazardous polymerisation will not occur.

Section 11 - TOXICOLOGICAL INFORMATION

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

The material has NOT been classified by EC Directives or other classification
systems as "harmful by ingestion". This is because of the lack of corroborating
animal or human evidence. The material may still be damaging to the health of
the individual, following ingestion, especially where pre-existing organ (e.g
liver, kidney) damage is evident. Present definitions of harmful or toxic
substances are generally based on doses producing mortality rather than those
producing morbidity (disease, ill-health). Gastrointestinal tract discomfort may
produce nausea and vomiting. In an occupational setting however, ingestion of
insignificant quantities is not thought to be cause for concern.

EYE

The material may be irritating to the eye, with prolonged contact causing
inflammation. Repeated or prolonged exposure to irritants may produce
conjunctivitis.
The liquid produces a high level of eye discomfort and is capable of causing
pain and severe conjunctivitis. Corneal injury may develop, with possible
permanent impairment of vision, if not promptly and adequately treated.

SKIN

Repeated exposure may cause skin cracking, flaking or drying following normal
handling and use.
The material may cause skin irritation after prolonged or repeated exposure and
may produce a contact dermatitis (nonallergic). This form of dermatitis is often
characterised by skin redness (erythema) and swelling the epidermis.
Histologically there may be intercellular oedema of the spongy layer
(spongiosis) and intracellular oedema of the epidermis.

INHALED

Inhalation of vapours may cause drowsiness and dizziness. This may be
accompanied by narcosis, drowsiness, reduced alertness, loss of reflexes, lack
of coordination and vertigo.
Exposure to ketone vapours may produce nose, throat and mucous membrane
irritation. High concentrations of vapour may produce central nervous system
depression characterised by headache, vertigo, loss of coordination, narcosis
and cardiorespiratory failure. Some ketones produce neurological disorders
(polyneuropathy) characterised by bilateral symmetrical paresthesia and muscle
weakness primarily in the legs and arms.
Acute effects from inhalation of high concentrations of vapour are pulmonary
irritation, including coughing, with nausea; central nervous system depression -
characterised by headache and dizziness, increased reaction time, fatigue and
loss of co-ordination

CHRONIC HEALTH EFFECTS

Prolonged or continuous skin contact with the liquid may cause defatting with drying,
cracking, irritation and dermatitis following. Chronic solvent inhalation exposures may
result in nervous system impairment and liver and blood changes. [PATTYS]. As with any
chemical product, contact with unprotected bare skin; inhalation of vapour, mist or dust
in work place atmosphere; or ingestion in any form, should be avoided by observing good
occupational work practice.

0890 100 62 - Wurth B+S Plastic/Wood/Stone Primer 250ml

Not available. Refer to individual constituents.
unless otherwise specified data extracted from RTECS - Register of Toxic Effects
of Chemical Substances

ETHYL ACETATE:
IRRITATION            TOXICITY
Eye (human): 400 ppm  Oral (rat) LD50: 5620 mg/kg
                      Inhalation (rat) LC50: 1600 ppm/8h
                      Inhalation (human) TCLo: 400 ppm

METHYL ETHYL KETONE:
TOXICITY                                 IRRITATION
Oral (rat) LD50: 2737 mg/kg              Eye (human): 350 ppm -irritant
Inhalation (human) TCLo: 100 ppm/5 m     Eye (rabbit): 80 mg - irritant
Inhalation (rat) LD50: 23500 mg/m3/8 hr  Skin (rabbit): 402 mg/24 hr - mild
Dermal (rabbit) LD50: 6480 mg/kg         Skin (rabbit):13.78mg/24 hr open
                                                                   - mild

N-BUTYL ACETATE:
TOXICITY                            IRRITATION
Oral (rat) LD50: 13100 mg/kg        Skin (rabbit): 500 mg/24h-moderate
Dermal (rabbit) LD50: 3200 mg/kg*   Eye (rabbit): 20 mg (open)-SEVERE
Inhalation (human) TCLo: 200 ppm    Eye (rabbit): 20 mg/24h - moderate
Inhalation (rat) LC50: 2000 ppm/4H  Eye ( human): 300 mg
                                                                    * [PPG]

XYLENE:
TOXICITY                             IRRITATION
Oral (human) LDLo: 50 mg/kg          Skin (rabbit):500 mg/24h moderate
Oral (rat) LD50: 4300 mg/kg          Eye (human): 200 ppm irritant
Inhalation (human) TCLo: 200 ppm     Eye (rabbit): 87 mg mild
Inhalation (man) LCLo: 10000 ppm/6h  Eye (rabbit): 5 mg/24h SEVERE
Inhalation (rat) LC50: 5000 ppm/4h
Reproductive effector in rats
The substance is classified by IARC as Group 3:
NOT classifiable as to its carcinogenicity to humans.
Evidence of carcinogenicity may be inadequate or limited in animal testing.

2-METHOXY-1-METHYLETHYL CYANOACETATE:
No significant acute toxicological data identified in literature search.

3-MERCAPTOPROPYLTRIMETHOXYSILANE:
TOXICITY                          IRRITATION
Oral (rat) LD50: 2940 mg/kg       Skin (rabbit):500 mg (open)-mild
Dermal (rabbit) LD50: 5880 mg/kg

Section 12 - ECOLOGICAL INFORMATION

DO NOT discharge into sewer or waterways.

Section 13 - DISPOSAL CONSIDERATIONS

· Consult manufacturer for recycling options and recycle where possible .
· Consult State Land Waste Management Authority for disposal.
· Incinerate residue at an approved site.
· Recycle containers if possible, or dispose of in an authorised landfill.

Section 14 - TRANSPORTATION INFORMATION

Shipping Name:
RESIN SOLUTION

Dangerous Goods Class: 3
UN/NA Number: 1866
ADR Number: 33
Packing Group: II
Labels Required: flammable liquid
Additional Shipping Information:
International Transport Regulations:
IMO: 3

HAZCHEM

3[Y]E

Section 15 - REGULATORY INFORMATION

POISONS SCHEDULE

S5

Section 16 - OTHER INFORMATION

 

This document is copyright. Apart from any fair dealing for the purposes of
private study, research, review or criticism, as permitted under the Copyright
Act, no part may be reproduced by any process without written permission from
CHEMWATCH. TEL (+61 3) 9572 4700.

 

Issue Date: Thu 30-Sep-2004

Print Date: Wed 9-Feb-2005